Navigation Links
Barriers to obtaining gene expression profiling test heightened perceived value
Date:6/17/2014

Barriers to obtaining gene expression profiling test heightened perceived value among patients, new study says TORONTO, June 17, 2014Barriers to obtaining gene expression profiling tests heightened their perceived importance among patients with early breast cancer who were deciding whether to have chemotherapy, a new study says.

Gene expression profiling tests, such as Oncotype Dx, analyze the patterns of 21 different genes within cancer cells to help predict how likely it is that a women's cancer will recur within 10 years after initial treatment and how beneficial chemotherapy will be to her.

Dr. Yvonne Bombard, a genomics and health services researcher in the Li Ka Shing Knowledge Institute of St. Michael's Hospital, found that access to this newly available and expensive technology is subject to careful administration and oversight.

However, she said that has created unintended consequences such as making oncologists gatekeepers for determining when it was medically appropriate for someone to have the test, leading to perceived inequalities in access by patients. Moreover, media attention made patients more aware of the gene expression profiling tests and led them to specifically ask for them, but that complicated physicians' gatekeeping efforts, sometimes hurting the doctor-patient relationship.

"There was a sense that the test was scarce or difficult to obtain, which heightened patients' desire for it and led them to perceive gene expression profiling tests as the deciding factor in their chemotherapy decisions, over and above other clinical tests and indicators," she said.

Dr. Bombard interviewed 14 oncologists and 28 breast cancer patients in Ontario for a study published today in Current Oncology. Ontario was the first province in Canada to fund gene expression profiling tests.

She said the careful oversight required of oncologists to the test created perceived inequities in access among patients. This often occurred in how oncologists discussed the test with their patients. Some oncologists offered the test to all their patients; others only to those who were eligible or where they felt there was uncertainty about the potential value of chemotherapy. Some raised it early in their consultations with patients, others late in the process, leading some patients to feel their doctors had already made the decision to recommend chemotherapy. Dr. Bombard said some patients felt information about the test was not offered to them because of its high cost, $4,000.

"Such delays or omissions in mentioning the test often left patients confused or feeling that something of great value was being withheld," she said.

Some patients said they learned about the tests from media reports describing a lack of funding in Canada that framed the issue as one of inequitable access to a highly effective, game-changing technology. Several of the oncologists said they felt pressured by the media coverage to offer the test to women for whom they knew it would not provide useful information for their decision-making about chemotherapy.

Another barrier was the extra paperwork around the test, which is not performed in Canada. Patients and oncologists must fill out forms to establish eligibility for OHIP reimbursement. Oncologists were then required to obtain government approval before sending tumour samples out of the country for testing. Results usually take about three weeks. This extra paperwork was cumbersome, increased anxieties about missing the window to start treatment and also reinforced the impression that the test was special, because it warranted special attention.


'/>"/>

Contact: Leslie Shepherd
shepherdl@smh.ca
416-864-6094
St. Michael's Hospital
Source:Eurekalert  

Related medicine news :

1. Study identifies barriers to breast health care in Pakistan
2. Kicking the habit -- new research examines the barriers to quitting smoking for smokers with asthma
3. Cultural, social factors identified as barriers to minority participation in stem cell donation
4. Personalized plans to address barriers to HIV drug adherence boost chances of successful therapy
5. Baylor University researchers study barriers, resources to physical activity in Texas towns
6. Affordable care alone may not be enough to help Latinos overcome cancer care barriers
7. Kids on Medicaid May Face Barriers to Eczema Treatment
8. Experts to present data addressing patient and physician barriers to clinical trials
9. BroadConnect Is Offering New Hosted PBX Bundle Pricing for New Customers, Eliminating VoIP Adoption Barriers
10. Research examines how technology can break down barriers
11. Egg-allergic children now have no barriers to flu shot
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Barriers to obtaining gene expression profiling test heightened perceived value
(Date:12/9/2016)... Heights, NY (PRWEB) , ... December 09, 2016 , ... ... Alcoholism and Drug Dependence, Inc. (NCADD) is recommending the film Whispering Spirits ... states and the District of Columbia as an education tool in the war against ...
(Date:12/9/2016)... ... 09, 2016 , ... An inventor from Cana, Va., wanted to fulfill the ... amusement park rides. , The patent-pending SAFETY STRAP FOR AMPUTEES improves accessibility. It eliminates ... be set up in a matter of minutes, or even seconds. The SAFETY STRAP ...
(Date:12/9/2016)... , ... December 09, 2016 , ... ... at The Pierre Hotel in New York, NY, on December 3rd, to benefit ... and physicians attended the annual event, which raised over $1 million - the ...
(Date:12/9/2016)... ... ... "I had a terrible time trying to get my grandson to use ... nebulizer had a more child-friendly design, then children would be more likely to look ... to avoid the need to deliver medication via a nebulizer mask. The design will ...
(Date:12/8/2016)... Charleston, WV (PRWEB) , ... December 08, 2016 ... ... that it will become Quality Insights beginning January 1, 2017. The name ... emphasizes its commitment to measuring and improving health care quality. , “We are ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... DUBLIN , Dec 9, 2016 ... "High-Throughput Screening Market - Forecast to 2021" report to ... ... adoption of open innovative models in the pharmaceutical and biotechnology ... spending and rising government funding. Emerging markets and growing research ...
(Date:12/9/2016)... , Dec 9, 2016 Research and Markets ... 2016-2020" report to their offering. ... The global travel vaccines market to grow ... The report covers the present scenario and the growth prospects of ... size, the report considers the revenue generated from the sales of ...
(Date:12/8/2016)... LONDON , Dec. 8, 2016 Australia ... GlobalData,s new report, "Australia Ophthalmic Lasers Market Outlook to ... Lasers market. The report provides value, in millions of ... within market segements - Excimer Lasers, Femtosecond Lasers and ... and distribution shares data for each of these market ...
Breaking Medicine Technology: